FDA After misleading and scaring readers about e-cigs, NY Times' Matt Richtel greatly exaggerates snus' risks, downplays health benefits for smokers

Status
Not open for further replies.

Bill Godshall

Executive Director<br/> Smokefree Pennsylvania
ECF Veteran
Apr 2, 2009
5,171
13,288
67
After misleading and scaring readers about e-cigs, NY Times’ Matt Richtel (in a lengthy article in Sunday's business section) similarly greatly exaggerates snus’ negligible risks and downplays its smoking cessation benefits (which are, like e-cigs, superior to NRT).

A lesser warning? Maybe
http://www.nytimes.com/2014/11/30/b...co-says-its-less-harmful-than-cigarettes.html

The article focuses on Swedish Match's MRTP application to FDA to truthfully claim that snus is less hazardous than cigarettes.

What I found particularly disturbing was that Richtel deceptively and falsely portrayed prominent ANTZ (e.g. FDA's Mitch Zeller, Legacy's Dave Abrams, Univ of Minnesota's Dorothy Hatsukami) as tobacco harm reduction advocates.

But in 2011 and 2012, GSK's Mitch Zeller, Legacy's Dave Abrams and Univ of Minn's Hatsukami lobbied the FDA to require dozens of unwarranted and costly studies for MRTP applications by smokeless tobacco companies to truthfully inform smokers that smokeless tobacco is less hazardous than cigarettes, which is why just one MRTP application has been submitted (a 100,000+ page application from Swedish Match costing millions of dollars).

The ANTZ are trying to marginalize all real THR advocates by playing a "good cop, bad cop" PR game with the news media (in which one faction of ANTZ are portrayed as THR advocates while another faction of ANTZ are portrayed as THR opponents).
By doing this, the major news media can ignore the real THR advocates, and falsely claim that THR advocates support all FDA tobacco and e-cig regulations.
 
Last edited:
Status
Not open for further replies.

Users who are viewing this thread